Comments
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve the Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 14, 2019 at the Registered Office of the Company inter-alia to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter Ended on June 30, 2019 along with any other business, if any. Further, in continuation to our disclosure on Closure of Trading Window dated June 28, 2019, pursuant to the provisions of the SEBI (PIT) Regulations, 2015 and the Companys Code of Conduct for Prevention of Insider Trading, it may be noted that the trading window has been closed for Designated Persons viz Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons from June 29, 2019 and shall reopen after the expiry of 48 hours from the time the result becomes generally available.
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.